Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer - Test2 - elhamkhani - TriplyDB

Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer

Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer

http://www.wikidata.org/entity/Q57758070

about

Implications of mismatch repair-deficient status on management of early stage colorectal cancer Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study.BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer.The prognostic value of simultaneous tumor and serum RAS/RAF mutations in localized colon cancer.Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic study Prognostic and predictive significance of MSI in stages II/III colon cancer.Current status of gene expression profiling to assist decision making in stage II colon cancer Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis.Meta-analysis of the prognostic value of smad4 immunohistochemistry in various cancers.Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy.Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer.Deciphering genomic alterations in colorectal cancer through transcriptional subtype-based network analysis Evaluation of relapse-free survival in T3N0 colon cancer: the role of chemotherapy, a multicentric retrospective analysis.A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer.Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer.Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage Single Nucleotide Polymorphism (rs4932178) in the P1 Promoter of FURIN Is Not Prognostic to Colon Cancer.The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials.TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.Microsatellite instability testing and its role in the management of colorectal cancer.IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal Cancers Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer.What is the optimal means of staging colon cancer?AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment?Colorectal Cancer: Personalized Therapy.Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location Biomarker in Colorectal Cancer.Striking similarities in genetic aberrations between a rectal tumor and its lung recurrence.Analysis of histological and immunological parameters of metastatic lymph nodes from colon cancer patients reveals that T-helper 1 type immune response is associated with improved overall survival.A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4.Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway.

P2860

Q26772272-3A209DDA-A6C9-47D8-8D27-761152DECE51 Q28080176-FC322765-5904-42DA-B583-9FE5618E0E61 Q30854540-1B13CABC-9858-4C81-A2A9-EF9D9DF0E572 Q33608167-12932406-F7DB-44C4-8439-778B8098D01B Q33615076-FC9E5541-5EDE-4AA8-A5E7-DE754B393650 Q33679614-573F7659-AAB1-463D-8893-3765300774ED Q33682949-6CECD86F-F710-450E-A54B-8531D528A6D5 Q33735239-4EA74EFF-7E90-4492-A768-2DF42F213213 Q33829763-1EEC50EC-FD3D-4B00-99D4-B68F3EB5BF5E Q34169734-8D5EAFF8-CCE8-405B-975E-C7419777A7BB Q34344060-5AEB4A86-8EEE-4731-8DCE-86DBEE4D183D Q34441837-77CFFF0C-F3E3-4391-9477-33C7FB0F8B64 Q34656360-B1164CCC-9078-47D1-A616-E62F872A260C Q34982575-E83ACEF1-D339-4C74-8EFD-495A5196A100 Q35001203-56D79B0D-79DC-48DC-8A92-2A5793AF5CED Q35048299-DFCBB6C5-89F8-4551-ADCC-DD5423183F51 Q35067307-5C361194-3DD3-44C6-A62A-1F72491DF148 Q35150637-5D16777F-B197-41C8-A544-71D48A4B3A17 Q35191237-E2BD056A-95F4-4D32-AA5A-BCCAD777472E Q35625752-6EF53868-75F3-4994-8AE0-54A72EDD4EA5 Q35763172-31F3B428-E8A2-43B8-B135-B5F7A2EAC6E7 Q35828678-36210DB0-15E7-43F3-A61C-67923711AF50 Q36006605-F032E142-8CFE-474D-B539-D50AF19E284E Q36038603-BF96FBB6-AD8B-441D-BACC-80E5FBA4D434 Q36090214-475F3244-B196-4F16-9A5C-289CD14D58DB Q36124008-787085F6-ADDA-4545-B667-0AE2E9CD96FE Q36289304-9321821B-64F9-4022-AC88-761D28E8198F Q36299382-2360D345-622E-4445-951B-1CEEACE2AE16 Q36315152-64DBEFAD-E86F-4166-8B1C-DDE625DC3C14 Q36315165-FD02B829-84CA-4074-BB0B-FE3C5D1EDEA3 Q36344547-09644820-DAEE-411D-A2AD-DB085AF0F561 Q37075412-8334B31E-4029-45C1-B4CE-B373E6EDDBE0 Q37111201-A666EBB7-ABE4-4BB5-A79D-AB570DA539E9 Q37114675-429E362F-3A73-427F-9ED8-0D967D823129 Q37310011-B7EC50EA-AD54-4B11-876C-8167B821F988 Q37409562-B4C42550-9457-4919-9527-8FCB9AC14241 Q37413869-F1F82859-651D-45C1-A3DE-D4D8781C5B11 Q37564379-D8725660-5581-429E-947D-A4554829376F Q37578728-098D0499-1646-4972-BD87-8F07A0FD45F7 Q37594355-A41C193F-8555-4453-9810-E19B1E009799

P2860

Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer

http://www.wikidata.org/entity/Q57758070

description

article

@en

im Oktober 2012 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2012

@uk

name

Integrated Analysis of Molecul ...... s in Stage II/III Colon Cancer

@en

Integrated Analysis of Molecul ...... s in Stage II/III Colon Cancer

@nl

type

label

Integrated Analysis of Molecul ...... s in Stage II/III Colon Cancer

@en

Integrated Analysis of Molecul ...... s in Stage II/III Colon Cancer

@nl

prefLabel

Integrated Analysis of Molecul ...... s in Stage II/III Colon Cancer

@en

Integrated Analysis of Molecul ...... s in Stage II/III Colon Cancer

@nl

P1433

Q57758070-B93FEACA-70AE-4B94-B45D-30D7F2D4E68F

P1476

Q57758070-ABF8BAAD-4934-4B34-A12E-9DB1F10820AB

P2093

Q57758070-3C7FC6F2-EE90-473E-B509-6AC6094EED4E

Q57758070-4197A3CB-18E5-462D-8913-7E2B00F9F82A

Q57758070-42C54AA6-F5E2-4EC5-B851-6DAEB220F83D

Q57758070-7A953950-AC80-4E5A-A61C-15B2AA1AC293

Q57758070-836E2B39-FAC5-448F-B3F4-2BD8EF97E1ED

Q57758070-8962C6D5-94AB-482F-8175-4C1F57730A29

Q57758070-9BA4DF32-EA7A-4981-B35A-E319B128DFBE

Q57758070-CC78EBD0-2FCB-4E12-9058-048AF85BA72F

Q57758070-E63FCC9C-8F38-414B-AAFF-BF101DC90C47

P2860

Q57758070-06825334-0690-4537-9E7A-15EBA5226B32

Q57758070-07A437D9-0DC3-4729-BE10-D2367033F034

Q57758070-19027496-DA6E-4D90-85C4-D9993CE92274

Q57758070-38E9B815-C858-4213-9052-80656C1213C4

Q57758070-39F5E960-8338-4E5E-A0E3-32124DC3179F

Q57758070-3D70B1A1-72AE-414E-BB91-AA9F84245EF3

Q57758070-4E95C40E-A200-4B49-8B7E-30D1CD42F807

Q57758070-5C971290-E970-41AE-BB82-76DC43B7AEAD

Q57758070-5FCDD662-A385-4B91-8CAC-4E00FE7A21D1

Q57758070-673C4219-3FCD-4804-8BCE-D53BEC0FB41E

P304

Q57758070-DC60DFE8-3343-4428-9568-B7B834ED6FF1

P31

Q57758070-124BF09B-129D-435B-A991-DB8F1C44732E

P356

Q57758070-8A9EA263-6ABB-4CE1-AD3C-3B64A7C3953B

P407

Q57758070-65C8B3E9-3DCC-4785-8C93-40CE03112549

P433

Q57758070-29B2477D-7CB1-4E89-9C1D-08D4D1F5F46B

P478

Q57758070-0787E77A-F3A3-4B03-BE81-D7564FD19E7A

P50

Q57758070-084F391B-8A40-4970-9B6F-74FA765596FC

Q57758070-61F28BBE-CD66-4B2B-AB8F-349DDF456F50

Q57758070-632E5215-4591-460F-942E-CE17F175BAF2

Q57758070-A900EC47-AD15-48DE-B084-5EF0192B7347

P577

Q57758070-A90368AE-E9EA-4DF7-B5EA-7C4596C60499

P698

Q57758070-B3001B97-9B1F-4D37-B631-99437D2D2AC7

P356

P1433

Journal of the National Cancer Institute

P1476

Integrated analysis of molecul ...... s in stage II/III colon cancer

@en

P2093

Arnaud D Roth

http://www.w3.org/2001/XMLSchema#string

Bernard Nordlinger

http://www.w3.org/2001/XMLSchema#string

Eric Van Cutsem

http://www.w3.org/2001/XMLSchema#string

Fred Bosman

http://www.w3.org/2001/XMLSchema#string

Giovanni d'Ario

http://www.w3.org/2001/XMLSchema#string

Laura Cisar

http://www.w3.org/2001/XMLSchema#string

Mauro Delorenzi

http://www.w3.org/2001/XMLSchema#string

Pu Yan

http://www.w3.org/2001/XMLSchema#string

Sabine Tejpar

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular origins of cancer: Molecular basis of colorectal cancer

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis

Molecular predictors of survival after adjuvant chemotherapy for colon cancer

Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes

Colorectal carcinogenesis: road maps to cancer.

Simpson's paradox visualized: the example of the rosiglitazone meta-analysis.

Revised TN categorization for colon cancer based on national survival outcomes data.

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.

Clinical trial designs for predictive biomarker validation: one size does not fit all.

P304

1635-1646

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJS427

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

David Cunningham

Roberto Labianca

P577

2012-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23104212

http://www.w3.org/2001/XMLSchema#string